Nebenwirkungen · Ibandronic Acid Teva
Ibandronic Acid Teva 50 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 6–7
HOS-212575 · Präparat HOS-154930
6 System Organ Common Uncommon Rare Very rare Not known Class Immune Hypersensitivit Asthma system y†, exacerbation disorders bronchospasm †, angioedema†, anaphylactic reaction/shock †* Metabolism Hypocalcaemi and nutrition a* disorders Nervous Paraesthesia, system dysgeusia disorders (taste perversion) Eye disorders Ocular inflammation† * Gastrointesti Oesophagitis, Haemorrhage, nal disorders abdominal duodenal pain, ulcer, gastritis, dyspepsia, dysphagia, dry nausea mouth Skin and Pruritus Stevens- subcutaneous Johnson tissue syndrome†, disorders erythema multiforme†, dermatitis bullous† Musculoskele Atypical Osteonecrosis Atypical tal and subtrochanteri of jaw†*, fractures of connective c and osteonecrosis long bones tissue diaphyseal of the external other than the disorders femoral auditory canal femur fractures† (bisphosphonat e class adverse reaction)† Renal and Azotaemia urinary (uraemia) disorders General Asthenia Chest pain, disorders and influenza-like administratio illness, n site malaise, pain conditions Investigations Blood parathyroid hormone increased *See further information below †Identified in postmarketing experience.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-08-28T16:00:09Z · SHA-256 a77d86843d2ecd9a9cc76a7966a88b66429aafa008e6f882df206e72867ec593 · Passage e43ccfc999306526ada24b543904975b7fe147fc2a5409476f286220aef23690 · Zeichen 1502–4904 im Abschnitt